Dyskinesia in a Prepubertal Boy After the First Dose of Methylphenidate and the Association of Focal Epileptiform Activity: A Case Report

Cevikaslan A., DUMAN Ö., Kutluk M. G.

ERCIYES MEDICAL JOURNAL, vol.42, no.4, pp.480-482, 2020 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 42 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.14744/etd.2019.04317
  • Journal Name: ERCIYES MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.480-482
  • Keywords: Dyskinesia, methylphenidate, movement disorder, Attention-Deficit/Hyperactivity Disorder, ADHD
  • Akdeniz University Affiliated: Yes

Abstract

Background: Methylphenidate is a piperidine derivative stimulant drug. It inhibits the reuptake of dopamine and norepinephrine and improves the primary symptoms of Attention-Deficit/Hyperactivity Disorder. Methylphenidate may cause dyskinesias in children with Attention-Deficit/Hyperactivity Disorder, and concomitant irregularity in Electroencephalography may increase the likelihood of the neuropsychiatric side effects.